KRBP
Kiromic BioPharma Inc

2,417
Mkt Cap
$157.00
Volume
250.00
52W High
$0.1496
52W Low
$0.00
Price
$0.0001
KRBP Fundamentals
Prev Close
$0.0001
Open
$0.0001
50D MA
$0.00
Beta
23.18
Avg. Volume
146.14
Loading...
Loading...

About

Kiromic Biopharma, Inc. is a clinical stage biotherapeutics company, which engages in DIAMOND AI and discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology. The firm is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of gamma delta T-cells to target solid cancers. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck on August 6, 2006 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Kiromic BioPharma Inc?
What is the 52-week high for Kiromic BioPharma Inc?
What is Kiromic BioPharma Inc stock price today?
What was Kiromic BioPharma Inc stock price yesterday?

Latest KRBP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.